MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 357 filers reported holding MEDIVATION INC in Q4 2015. The put-call ratio across all filers is 0.48 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,275,000 | -20.6% | 100,790 | -41.4% | 0.36% | -20.7% |
| Q1 2016 | $7,907,000 | -8.0% | 171,956 | -3.3% | 0.45% | +18.7% |
| Q4 2015 | $8,595,000 | -0.7% | 177,801 | -12.7% | 0.38% | -16.9% |
| Q3 2015 | $8,654,000 | -30.1% | 203,628 | +87.9% | 0.46% | -10.6% |
| Q2 2015 | $12,373,000 | -15.7% | 108,346 | -4.7% | 0.51% | -11.9% |
| Q1 2015 | $14,679,000 | +15.7% | 113,730 | -10.7% | 0.58% | +8.6% |
| Q4 2014 | $12,692,000 | -17.7% | 127,420 | -18.4% | 0.53% | -17.4% |
| Q3 2014 | $15,429,000 | -11.3% | 156,058 | -30.9% | 0.64% | -4.3% |
| Q2 2014 | $17,397,000 | +24.2% | 225,696 | +3.7% | 0.67% | +26.7% |
| Q1 2014 | $14,004,000 | -3.8% | 217,557 | -4.6% | 0.53% | +1.5% |
| Q4 2013 | $14,561,000 | -10.1% | 228,158 | -15.6% | 0.52% | -22.0% |
| Q3 2013 | $16,196,000 | – | 270,204 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |